Northeast Financial Consultants’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,646
| Closed | -$203K | – | 308 |
|
|
2023
Q1 | $203K | Hold |
8,646
| – | – | 0.01% | 298 |
|
|
2022
Q4 | $235K | Hold |
8,646
| – | – | 0.02% | 275 |
|
|
2022
Q3 | $465K | Hold |
8,646
| – | – | 0.03% | 199 |
|
|
2022
Q2 | $349K | Hold |
8,646
| – | – | 0.02% | 239 |
|
|
2022
Q1 | $573K | Hold |
8,646
| – | – | 0.03% | 209 |
|
|
2021
Q4 | $865K | Buy |
8,646
+1,698
| +24% | +$170K | 0.05% | 168 |
|
|
2021
Q3 | $869K | Buy |
6,948
+1,441
| +26% | +$180K | 0.06% | 172 |
|
|
2021
Q2 | $684K | Hold |
5,507
| – | – | 0.05% | 187 |
|
|
2021
Q1 | $841K | Hold |
5,507
| – | – | 0.06% | 157 |
|
|
2020
Q4 | $710K | Hold |
5,507
| – | – | 0.06% | 158 |
|
|
2020
Q3 | $616K | Hold |
5,507
| – | – | 0.06% | 154 |
|
|
2020
Q2 | $447K | Buy |
5,507
+252
| +5% | +$20.5K | 0.04% | 182 |
|
|
2020
Q1 | $366K | Buy |
+5,255
| New | +$366K | 0.04% | 185 |
|